Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Health Economics Review
Published in: Health Economics Review 1/2020

01-12-2020 | Schizophrenia | Review

The impact of social, national and community-based health insurance on health care utilization for mental, neurological and substance-use disorders in low- and middle-income countries: a systematic review

Authors: Sumaiyah Docrat, Donela Besada, Susan Cleary, Crick Lund

Published in: Health Economics Review | Issue 1/2020

Login to get access

Abstract

Background

Whilst several systematic reviews conducted in Low- and Middle-Income Countries (LMICs) have revealed that coverage under social (SHI), national (NHI) and community-based (CBHI) health insurance has led to increased utilization of health care services, it remains unknown whether, and what aspects of, these shifts in financing result in improvements to mental health care utilization. The main aim of this review was to examine the impact of SHI, NHI and CBHI enrollment on mental health care utilization in LMICs.

Methods

Systematic searches were performed in nine databases of peer-reviewed journal articles: Pubmed, Scopus, SciELO via Web of Science, Africa Wide, CINAHL, PsychInfo, Academic Search Premier, Health Source Nursing Academic and EconLit for studies published before October 2018. The quality of the studies was assessed using the Effective Public Health Practice Project quality assessment tool for quantitative studies. The systematic review was reported according to the PRISMA guidelines (PROSPERO;2018; CRD42018111576).

Results

Eighteen studies were included in the review. Despite some heterogeneity across countries, the results demonstrated that enrollment in SHI, CBHI and NHI schemes increased utilization of mental health care. This was consistent for the length of inpatient admissions, number of hospitalizations, outpatient use of rehabilitation services, having ever received treatment for diagnosed schizophrenia and depression, compliance with drug therapies and the prescriptions of more favorable medications and therapies, when compared to the uninsured. The majority of included studies did not describe the insurance schemes and their organizational details at length, with limited discussion of the links between these features and the outcomes. Given the complexity of mental health service utilization in these diverse contexts, it was difficult to draw overall judgements on whether the impact of insurance enrollment was positive or negative for mental health care outcomes.

Conclusions

Studies that explore the impact of SHI, NHI and CBHI enrollment on mental health care utilization are limited both in number and scope. Despite the fact that many LMICs have been hailed for financing reforms towards universal health coverage, evidence on the positive impact of the reforms on mental health care utilization is only available for a small sub-set of these countries.
Appendix
Available only for authorised users
Literature
1.
WHO. Health Systems Financing: The Path to Universal Coverage. Geneva: World Health Organization; 2010.
2.
McIntyre D, Ranson MK, Aulakh BK, Honda A. Promoting universal financial protection: evidence from seven low- and middle-income countries on factors facilitating or hindering progress. Health Res Policy Syst. 2013;11:36.PubMedPubMedCentralCrossRef
3.
WHA58.33. Sustainable health financing, universal coverage and social health insurance WHA58.33 (2005).
4.
Savedoff WD, de Ferranti D, Smith AL, Fan V. Political and economic aspects of the transition to universal health coverage. Lancet. 2012;380(9845):924–32.PubMedCrossRef
5.
Carrin G, Mathauer I, Xu K, Evans DB. Universal coverage of health services: tailoring its implementation. Bull World Health Organ. 2008;86(11):857–63.PubMedPubMedCentralCrossRef
6.
WHO. The World Health Report [2010]: Health Systems Financing; the Path to Universal Coverage. 2010.
7.
Gottret P, Schieber G, Waters HR. Good practices in health financing: lessons from reforms in low and middle-income countries: the World Bank; 2008.CrossRef
8.
Lagomarsino G, Garabrant A, Adyas A, Muga R, Otoo N. Moving towards universal health coverage: health insurance reforms in nine developing countries in Africa and Asia. Lancet. 2012;380(9845):933–43.PubMedCrossRef
9.
10.
Kutzin J. Health financing for universal coverage and health system performance: concepts and implications for policy. Bull World Health Organ. 2013;91(8):602–11.PubMedPubMedCentralCrossRef
11.
McIntyre D, Van den Heever A. Social or national health insurance: pooling of resources and purchasing of health care. South Afr Health Rev. 2007;2007(1):71–87.
12.
McIntyre D, Kutzin J. Health financing country diagnostic: a foundation for national strategy development. Geneva: World Health Organization; 2016.
13.
14.
Spaan E, Mathijssen J, Tromp N, McBain F, Have A, Baltussen R. The impact of health insurance in Africa and Asia: a systematic review. Bull World Health Organ. 2012;90:685–92.PubMedPubMedCentralCrossRef
15.
Giedion UAE, Diaz Y. The impact of universal coverage schemes in the developing world: a review of the existing evidence. Washington DC: World Bank; 2013.
16.
17.
Patel V, Saxena S, Lund C, Thornicroft G, Baingana F, Bolton P, et al. The lancet commission on global mental health and sustainable development. Lancet. 2018;392(10157):1553–98.PubMedCrossRef
18.
Thornicroft G, Chatterji S, Evans-Lacko S, Gruber M, Sampson N, Aguilar-Gaxiola S, et al. Undertreatment of people with major depressive disorder in 21 countries. Br J Psychiatry. 2017;210(2):119–24.PubMedPubMedCentralCrossRef
19.
Alonso J, Liu Z, Evans-Lacko S, Sadikova E, Sampson N, Chatterji S, et al. Treatment gap for anxiety disorders is global: results of the world mental health surveys in 21 countries. Depress Anxiety. 2018;35(3):195–208.PubMedPubMedCentralCrossRef
20.
Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine J, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization world mental health surveys. Jama. 2004;291(21):2581–90.PubMedCrossRef
21.
Chisholm D, Docrat S, Abdulmalik J, Alem A, Gureje O, Gurung D, et al. Mental health financing challenges, opportunities and strategies in low- and middle-income countries: findings from the emerald project. BJPsych Open. 2019;5(5):e68.PubMedPubMedCentralCrossRef
22.
Docrat S, Lund C, Chisholm D. Sustainable financing options for mental health care in South Africa: findings from a situation analysis and key informant interviews. Int J Ment Heal Syst. 2019;13:4.CrossRef
23.
Prinja S, Chauhan AS, Karan A, Kaur G, Kumar R. Impact of publicly financed health insurance schemes on healthcare utilization and financial risk protection in India: a systematic review. PLoS One. 2017;12(2):e0170996.PubMedPubMedCentralCrossRef
24.
Acharya A, Vellakkal S, Taylor F, Masset E, Satija A, Burke M, et al. The impact of health insurance schemes for the informal sector in low-and middle-income countries: a systematic review. World Bank Res Obs. 2012;28(2):236–66.CrossRef
25.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.PubMedCrossRef
26.
Endnote. Endnote. X7 ed. San Fransisco: Thomson Reuters; 2015.
27.
28.
Ding X, Zheng Y, Guo Y, Shen C, Wang S, Chen F, et al. Active epilepsy prevalence, the treatment gap, and treatment gap risk profile in eastern China: a population-based study. Epilepsy Behav. 2018;78:20–4.PubMedCrossRef
29.
Feng Y, Xiong X, Xue Q, Yao L, Luo F, Xiang L. The impact of medical insurance policies on the hospitalization services utilization of people with schizophrenia: A case study in Changsha, China. Pakistan J Med Sci. 2012;29:3.
30.
He P, Guo C, Luo Y, Wen X, Salas JMI, Chen G, et al. Trends in rehabilitation services use in Chinese children and adolescents with intellectual disabilities: 2007-2013. Arch Phys Med Rehabil. 2017;98(12):2408–15.PubMedCrossRef
31.
Jian W, Guo Y. Does per-diem reimbursement necessarily increase length of stay? The case of a public psychiatric hospital. Health Econ. 2009;18(Suppl 2):S97–106.PubMedCrossRef
32.
Wang Z-M, Zhu H, Pan Y-L, Chiu HFK, Correll CU, Ungvari GS, et al. Electroconvulsive therapy and its association with demographic and clinical characteristics in Chinese psychiatric patients. J Ect. 2015;31(2):114–8.PubMedCrossRef
33.
Xu J, Wang J, King M, Liu R, Yu F, Xing J, et al. Rural-urban disparities in the utilization of mental health inpatient services in China: the role of health insurance. Int J Health Econ Manag. 2018;18(4):377.PubMedPubMedCentralCrossRef
34.
Xue Q, Xiong X, Feng Y, Yao L, Chen S, Xiang L. Socioeconomic factors influencing antipsychotic prescription for schizophrenia inpatients in China: a cross-sectional study. Int Clin Psychopharmacol. 2014;29(5):288–95.PubMedCrossRef
35.
Yu-tao X, Yong-zhen W, Chi-Ming L, Wai-Kwong T, Ungvari GS. Clinical correlates of clozapine prescription for schizophrenia in China. Hum Psychopharmacol. 2007;22(1):17–25.CrossRef
36.
Yu-Tao X, Yong-Zhen W, Chi-Ming L, Wai-Kwong T, Ungavri GS. Exploring the clinical and social determinants of prescribing anticholinergic medication for Chinese patients with schizophrenia. Human Psychopharmacol. 2007;22(3):173–80.CrossRef
37.
Zhang X-Q, Wang Z-M, Pan Y-L, Chiu HFK, Ng CH, Ungvari GS, et al. Use of electroconvulsive therapy in older Chinese psychiatric patients. Int J Geriatr Psychiatry. 2015;30(8):851–6.PubMedCrossRef
38.
Zhou Y, Rosenheck RA, He H. Health Insurance in China: variation in co-payments and psychiatric hospital utilization. J Ment Health Policy Econ. 2014;17(1):25–32.PubMed
39.
Zhou Y, Rosenheck R, Mohamed S, Ning Y, He H. Factors associated with complete discontinuation of medication among patients with schizophrenia in the year after hospital discharge. Psychiatry Res. 2017;250:129–35.PubMedCrossRef
40.
Chung W, Chang H-S, Oh S-M, Yoon C-W. Factors associated with long-stay status in patients with schizophrenia: an analysis of national databases covering the entire Korean population. Int J Soc Psychiatry. 2013;59(3):207–16.PubMedCrossRef
41.
Hwang JE, Song I, Lee E-K, Ha D, Shin J-Y. Prevalence and predictors of tricyclic antidepressant use among elderly Koreans in primary-care and specialty clinics. Int J Clin Pharmacol Ther. 2018;56(5):224–30.PubMedCrossRef
42.
Asawavichienjinda T, Sitthi-Amorn C, Tanyanont W. Compliance with treatment of adult epileptics in a rural district of Thailand. Journal of the medical Association of Thailand =. Chotmaihet Thangphaet. 2003;86(1):46–51.PubMed
43.
Hirunrassamee S, Ratanawijitrasin S. Does your health care depend on how your insurer pays providers? Variation in utilization and outcomes in Thailand. Int J Health Care Finance Econ. 2009;9(2):153–68.PubMedCrossRef
44.
Araya R, Lewis G, Rojas G, Fritsch R, Frank R. Inequities in mental health care after health care system Reform in Chile. Am J Public Health. 2006;96(1):109–13.PubMedPubMedCentralCrossRef
45.
El-Sayed AM, Palma A, Freedman LP, Kruk ME. Does health insurance mitigate inequities in non-communicable disease treatment? Evidence from 48 low- and middle-income countries. Health policy (Amsterdam, Netherlands). 2015;119(9):1164–75.CrossRef
46.
De Berardis D, Rapini G, Olivieri L, Di Nicola D, Tomasetti C, Valchera A, et al. Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine. Ther Adv Drug Saf. 2018;9(5):237–56.PubMedPubMedCentralCrossRef
47.
Yuan B, He L, Meng Q, Jia L. Payment methods for outpatient care facilities. Cochrane Database Syst Rev. 2017;3:Cd011153.PubMed
48.
Liu GG, Vortherms SA, Hong X. China's health Reform update. Annu Rev Public Health. 2017;38(1):431–48.PubMedCrossRef
49.
Reich MR, Harris J, Ikegami N, Maeda A, Cashin C, Araujo EC, et al. Moving towards universal health coverage: lessons from 11 country studies. Lancet (London, England). 2016;387(10020):811–6.CrossRef
50.
Fadlallah R, El-Jardali F, Hemadi N, Morsi RZ, Abou Samra CA, Ahmad A, et al. Barriers and facilitators to implementation, uptake and sustainability of community-based health insurance schemes in low- and middle-income countries: a systematic review. Int J Equity Health. 2018;17(1):13.PubMedPubMedCentralCrossRef
51.
Sumriddetchkajorn K, Shimazaki K, Ono T, Kusaba T, Sato K, Kobayashi N. Universal health coverage and primary care, Thailand. Bull World Health Organ. 2019;97(6):415–22.PubMedPubMedCentralCrossRef
52.
Yu H. Universal health insurance coverage for 1.3 billion people: What accounts for China’s success? Health Policy (Amsterdam, Netherlands). 2015;119(9):1145–52.CrossRef
53.
Koch KJ, Cid Pedraza C, Schmid A. Out-of-pocket expenditure and financial protection in the Chilean health care system—A systematic review. Health Policy (Amsterdam, Netherlands). 2017;121(5):481–94.CrossRef
54.
Liang D, Mays VM, Hwang W-C. Integrated mental health services in China: challenges and planning for the future. Health Policy Plan. 2018;33(1):107–22.PubMedCrossRef
55.
Ng C. Mental health and integration in Asia Pacific. BJPsych International. 2018:1–3.
56.
Reform A C’s H. Increase in coverage and access, decline in hospitalization and death rates. Health Aff. 2010;29(12):2161–70.CrossRef
57.
Smith PC, Chalkidou K. Should countries set an explicit health benefits package? The case of the English National Health Service. Value Health. 2017;20(1):60–6.PubMedPubMedCentralCrossRef
58.
World Health Organization and World Bank Tracking Universal Health Coverage: First Global Monitoring Report. Geneva: World Health Organization; 2013.
59.
PVJ F. Universal health coverage with equity: what we know, don’t know and need to know. Montreux: Global Symposium on Health Systems Research, 16–19 November 2010; 2019.
60.
Patel V, Maj M, Flisher AJ, De Silva MJ, Koschorke M, Prince M, et al. Reducing the treatment gap for mental disorders: a WPA survey. World Psychiatry. 2010;9(3):169–76.PubMedPubMedCentralCrossRef
61.
Thornicroft G, Patel V. Including mentalhealth among the new sustainable development goals. BMJ (Clinical research ed). 2014;349:g5189.
62.
Chisholm D, Flisher AJ, Lund C, Patel V, Saxena S, Thornicroft G, et al. Scale up services for mental disorders: a call for action. Lancet. 2007;370(9594):1241–52.PubMedCrossRef
63.
WHO. mhGAP intervention guide for mental, neurological and substance use disorders in non-specialized health settings. Geneva: World Health Organization; 2010.
64.
Hanlon C, Semrau M, Alem A, Abayneh S, Abdulmalik J, Docrat S, et al. Evaluating capacity-building for mental health system strengthening in low- and middle-income countries for service users and caregivers, service planners and researchers. Epidemiol Psychiatr Sci. 2018;27(1):3–10.PubMedCrossRef
65.
Hanlon C, Luitel NP, Kathree T, Murhar V, Shrivasta S, Medhin G, et al. Challenges and opportunities for implementing integrated mental health care: a district level situation analysis from five low- and middle-income countries. PLoS One. 2014;9(2):e88437.PubMedPubMedCentralCrossRef
66.
Lund C, Tomlinson M, De Silva M, Fekadu A, Shidhaye R, Jordans M, et al. PRIME: a programme to reduce the treatment gap for mental disorders in five low-and middle-income countries. PLoS Med. 2012;9(12):e1001359.PubMedPubMedCentralCrossRef
67.
Lund C. Poverty and mental health: unlocking the potential for sustainable human development. TEDxCapeTown 2016; 15 October 2016; Century City, Cape Town, South Africa2016.
68.
WHO. The World Health Report 2013: Research for universal health coverage. Geneva: World Health Organization; 2013.
69.
Rodney AM, Hill PS. Achieving equity within universal health coverage: a narrative review of progress and resources for measuring success. Int J Equity Health. 2014;13(1):72.PubMedPubMedCentralCrossRef
Metadata
Title
The impact of social, national and community-based health insurance on health care utilization for mental, neurological and substance-use disorders in low- and middle-income countries: a systematic review
Authors
Sumaiyah Docrat
Donela Besada
Susan Cleary
Crick Lund
Publication date
01-12-2020
Publisher
Springer Berlin Heidelberg
Published in
Health Economics Review / Issue 1/2020
Electronic ISSN: 2191-1991
DOI
https://doi.org/10.1186/s13561-020-00268-x

Other articles of this Issue 1/2020

Health Economics Review 1/2020 Go to the issue

Research

Cost of care for persons with dementia: using a discrete-time Markov chain approach with administrative and clinical data from the dementia service Centres in Austria

Correction

Correction to: The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain

Research

Determinants of healthcare seeking and out-of-pocket expenditures in a “free” healthcare system: evidence from rural Malawi

Research

Comorbidities and HCV coinfection in the management of HIV+ patients: evidence from the Italian clinical practice

Research

Effects of health insurance on patient demand for physician services

Research

The long-term effects of cancer survivorship on household assets